4th Quarter - Report

POLSINELLI PC for THE ADVERTISING COALITION

Firm
Client
Income
$140,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Advertising ADV

FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act

LobbyistCovered position, as disclosed
JAMES DAVIDSON —
SYLVIA STANOJEV KORNEGAY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4106 (116th), S. 2550 (116th), S. 1437 (116th), S. 1801 (116th), S. 73 (116th), H.R. 4711 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.